Latest filing published 21 Jun 2023 for 立方制药, €20k.
Filing timeline
BuySaleInsider track record
汪琴: trading record in brief
汪琴 is a declared insider of 立方制药, with filings sourced from SSE / SZSE (CSRC). In total, 7 filings cover trades dated from 13 June 2023 to 21 June 2023.
Sales make up the whole of the open-market record (7 sales, €182k).
The newest entry dates from 21 June 2023: an open-market sale of €20k, in 立方制药. Publication is fast: at least half of the trades appear on SSE / SZSE (CSRC) on the same day. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Companies and markets linked to 汪琴
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,000 shares10.8% of flowA股XSHESZSE:173000006680026460
- 4,000 shares10.9% of flowA股XSHESZSE:173000006672223800
- 3,000 shares8.6% of flowA股XSHESZSE:173000006669480220
- 5,000 shares14.2% of flowA股XSHESZSE:173000006666953950
- 2,000 shares5.7% of flowA股XSHESZSE:173000006663043170
- 5,000 shares14.5% of flowA股XSHESZSE:173000006660074430
- 12,000 shares35.3% of flowA股XSHESZSE:173000006657349250
7 of 7 declarations